Clinical Trials on Heavy MHS Use in Australia
Total 73 results
-
Medical University of ViennaCompletedCoronary Artery Disease | Ischemic Heart Disease | Heavy Metal ToxicityAustria
-
Sydney Centre for Reproductive Health ResearchMerck Sharp & Dohme LLCUnknown
-
Delpor, Inc.CompletedOpiod Use DisorderAustralia
-
Turning PointMonash University; Eastern Health; Deakin UniversityCompletedMethamphetamine Use DisorderAustralia
-
Monash UniversityHeadspace, IncCompleted
-
Turning PointMonash University; Eastern Health; National Centre for Clinical Research on Emerging...RecruitingMethamphetamine Use DisorderAustralia
-
Monash UniversityTurning PointCompletedCannabis Use Disorder, Moderate | Cannabis Use Disorder, SevereAustralia
-
Kinoxis Therapeutics Pty LtdNational Institute on Drug Abuse (NIDA)CompletedOpioid-use Disorder | Healthy Volunteer StudyAustralia
-
South West Sydney Local Health DistrictUniversity of Sydney; Lambert Initiative for Cannabinoid TherapeuticsRecruitingAlcohol Use Disorder (AUD)Australia
-
University of SydneyMonash UniversityRecruitingAlcohol Use Disorder (AUD)Australia
-
Turning PointSt Vincent's Hospital Melbourne; Monash Health; Uniting Vic Tas; Star Health; Odyssey...Completed
-
The Queen Elizabeth HospitalUniversity of AdelaideCompletedTobacco DependenceAustralia
-
The University of QueenslandNational Health and Medical Research Council, AustraliaRecruitingAntibiotics Causing Adverse Effects in Therapeutic Use | Antimicrobial StewardshipAustralia
-
Turning PointMonash University; Eastern HealthRecruiting
-
The Queen Elizabeth HospitalCompleted
-
University of LeipzigDeutsche Krebshilfe e.V., Bonn (Germany)RecruitingMDS | MDS/MPNGermany, Austria
-
OrygenUniversity of Melbourne; Youth Support and Advocacy ServiceRecruitingCannabis Use DisorderAustralia
-
The Florey Institute of Neuroscience and Mental...Melbourne Health; St Vincent's Hospital MelbourneTerminatedInsomnia | Alcohol Use DisorderAustralia
-
YourResearchProject Pty LtdÖssur EhfRecruitingAmputation | Prosthesis UserAustralia
-
Peter MacCallum Cancer Centre, AustraliaGlaxoSmithKline; Celgene CorporationCompletedMyelodysplastic Syndromes (MDS) | Acute Myeloid Leukaemia (AML)Australia
-
Otsuka Australia Pharmaceutical Pty LtdCompletedMyelodysplastic Syndrome (MDS)Australia
-
The University of QueenslandCompletedAge Related Macular Degeneration | Lutein and Zeaxanthin Dietary Intake | Blue Light Exposure | Electronic Device UseAustralia
-
GWT-TUD GmbHRecruiting
-
University of SydneyMonash University; Sydney Local Health DistrictRecruitingAlcohol Dependence | PTSD | Alcohol Use Disorder | Post-traumatic Stress Disorder | Comorbidities and Coexisting ConditionsAustralia
-
AbbVieCelgene; Genentech, Inc.CompletedMyelodysplastic Syndromes (MDS)United States, Australia, Germany
-
Center of Integrative Addiction Research, AustriaMedical University of GrazUnknownSubstance Use Disorders | PsychotherapyAustria
-
The University of New South WalesAustralian Government Department of Health and AgeingCompletedBehavior, Addictive | Psychotic DisorderAustralia
-
Ultragenyx Pharmaceutical IncAbeona Therapeutics, IncTerminatedMucopolysaccharidosis III | Sanfilippo Syndrome | MPS IIIA | Sanfilippo AUnited States, Spain, Australia
-
AbbVieGenentech, Inc.Active, not recruitingMyelodysplastic Syndromes (MDS)United States, Australia, Canada, France, Germany, Italy, United Kingdom
-
Ultragenyx Pharmaceutical IncAbeona Therapeutics, IncActive, not recruitingMucopolysaccharidosis III | Sanfilippo Syndrome | MPS IIIA | Sanfilippo AUnited States, Australia, Spain
-
Medical University InnsbruckCompletedSubstance Abuse | Nicotine Dependence | Tobacco Dependence | Substance DependenceAustria
-
University of Notre Dame AustraliaSt Vincent's Hospital, SydneyCompletedPain, Postoperative | Surgery | Opioid-related Disorders | Opiate Addiction | Opioid Use Disorders | Post-operative ComplicationsAustralia
-
Novartis PharmaceuticalsActive, not recruitingAcute Myeloid Leukemia (AML) | High-risk Myelodysplastic Syndrome (MDS)Spain, Singapore, Australia, Germany, Italy, Finland, United States
-
Humanigen, Inc.SuspendedMyelodysplastic Syndrome (MDS) | Myelofibrosis (MF)United States, Australia
-
Array BioPharmaCompletedAML | Advanced and Selected Solid Tumors | High Risk and Very High Risk MDSUnited States, Australia, Italy, Spain, France, Switzerland, United Kingdom
-
Allievex CorporationCompletedMucopolysaccharidosis Type IIIB | Mucopolysaccharidosis Type 3 B | MPS III B | MPS 3 BUnited States, Spain, Turkey, Taiwan, Australia, Colombia, Germany, United Kingdom
-
Institut de Recherches Internationales ServierADIR, a Servier Group companyCompletedMyelodysplastic Syndrome (MDS) | Acute Myeloid Leukaemia (AML)France, Australia
-
Medical University of ViennaAustrian Science Fund (FWF)Active, not recruitingHeart Failure | Artificial Heart Device UserAustria
-
AmgenCompletedBlincyto Use in Routine Clinical PracticeNetherlands, France, Czechia, Sweden, Austria, Italy, Switzerland, Germany, Finland, United Kingdom, Portugal, Greece, Poland
-
Novartis PharmaceuticalsCompletedThalassemia, Non-transfusional-dependent Thalassemia (NTDT), Myeloplastic Dysplasia (MDS), Other AnemiaAustralia
-
Senti BiosciencesRecruitingAML/MDS | CD33 Expressing Hematological Malignancies | FLT3 Expressing Hematological MalignanciesUnited States, Australia
-
Medical University of ViennaLund University; Helsinki University Central Hospital; Sykehuset Innlandet HF; University... and other collaboratorsCompletedAmputation | Prosthesis UserAustria, Finland, Germany, Norway, Sweden
-
Institut de Recherches Internationales ServierActive, not recruitingLeukemia, Myeloid, Acute | Untreated AML | Newly Diagnosed Acute Myeloid Leukemia (AML) | AML Arising From Myelodysplastic Syndrome (MDS)Spain, United States, France, Korea, Republic of, Taiwan, Australia, Canada, Germany, China, Italy, Austria, Czechia, Poland, Japan, United Kingdom, Russian Federation, Netherlands, Brazil, Israel, Mexico
-
Institut de Recherches Internationales ServierADIR, a Servier Group companyCompletedMyelodysplastic Syndrome (MDS) | Acute Myeloid Leukaemia (AML)United States, Australia, France, Spain
-
BioMarin PharmaceuticalCompletedMPS VIUnited States, Australia, France, Brazil, Germany, Portugal, United Kingdom
-
Novartis PharmaceuticalsCompletedAML and High Risk MDSGermany, Italy, France, Netherlands, United States, Australia, Japan
-
BioMarin PharmaceuticalCompletedMucopolysaccharidosis VI (MPS VI, Maroteaux-Lamy Syndrome)United States, France, Australia, Germany, Ireland, Austria, Belgium, Italy, Lithuania, Netherlands, Portugal, Sweden, United Kingdom
-
Braeburn PharmaceuticalsCompletedOpioid Use DisorderUnited States, United Kingdom, Taiwan, Hungary, Australia, Denmark, Germany, Sweden
-
Radboud University Medical CenterRecruitingMyelodysplastic Syndromes (MDS)Denmark, Switzerland, Serbia, Austria, Croatia, Czechia, France, Germany, Greece, Israel, Italy, Netherlands, Poland, Portugal, Romania, Spain, Sweden, United Kingdom
-
CelgeneRecruitingBeta-thalassemia | Myelodysplastic Syndromes (MDS) | Myeloproliferative Neoplasm(MPN)-Associated MyelofibrosisUnited States, Japan, Israel, United Kingdom, Turkey, Greece, France, Australia, Belgium, Bulgaria, Canada, Germany, Italy, Malaysia, Spain, Sweden, Taiwan, Thailand, Tunisia, China, Lebanon, Netherlands